本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

3.15
0.0000
盘后3.180.0299+0.95%19:59 EDT
成交量:1,483.76万
成交额:4,744.97万
市值:16.61亿
市盈率:-2.70
高:3.30
开:3.20
低:3.12
收:3.15
52周最高:7.18
52周最低:2.77
股本:5.27亿
流通股本:4.15亿
量比:0.70
换手率:3.58%
股息:- -
股息率:- -
每股收益(TTM):-1.1684
每股收益(LYR):-1.4410
净资产收益率:-57.16%
总资产收益率:-27.66%
市净率:1.62
市盈率(LYR):-2.19

数据加载中...

2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 | RECURSION PHARMACEUTICALS董事Borgeson Blake拟减持170000股,总价约588200美元